| 37688579 | Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival. | J Natl Cancer Inst | 2024 |
| 37688579 | Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival. | J Natl Cancer Inst | 2024 |
| 36541551 | Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants. | Neuro Oncol | 2023 |
| 37584517 | Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors. | Cancer Res | 2023 |
| 37015164 | Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. | Psychiatry Res | 2023 |
| 36747619 | Germline pathogenic variants in 786 neuroblastoma patients. | medRxiv | 2023 |
| 37185055 | Tobacco use in first-episode psychosis, a multinational EU-GEI study. | Psychol Med | 2023 |
| 36541551 | Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variants. | Neuro Oncol | 2023 |
| 37584517 | Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors. | Cancer Res | 2023 |
| 37185055 | Tobacco use in first-episode psychosis, a multinational EU-GEI study. | Psychol Med | 2023 |
| 37015164 | Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. | Psychiatry Res | 2023 |
| 36747619 | Germline pathogenic variants in 786 neuroblastoma patients. | medRxiv | 2023 |
| 33070791 | Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway. | Psychol Med | 2022 |
| 36055075 | The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. | Eur Neuropsychopharmacol | 2022 |
| 33046166 | A replication study of JTC bias, genetic liability for psychosis and delusional ideation. | Psychol Med | 2022 |
| 33070791 | Evidence, and replication thereof, that molecular-genetic and environmental risks for psychosis impact through an affective pathway. | Psychol Med | 2022 |
| 34536513 | Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study. | Prog Neuropsychopharmacol Biol Psychiatry | 2022 |
| 36055075 | The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. | Eur Neuropsychopharmacol | 2022 |
| 34536513 | Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study. | Prog Neuropsychopharmacol Biol Psychiatry | 2022 |
| 33046166 | A replication study of JTC bias, genetic liability for psychosis and delusional ideation. | Psychol Med | 2022 |
| 33051644 | svpluscnv: analysis and visualization of complex structural variation data. | Bioinformatics | 2021 |
| 33736735 | Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. | Eur Psychiatry | 2021 |
| 33602789 | GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma. | Cancer Res | 2021 |
| 33051644 | svpluscnv: analysis and visualization of complex structural variation data. | Bioinformatics | 2021 |
| 33602789 | GAS7 Deficiency Promotes Metastasis in MYCN-Driven Neuroblastoma. | Cancer Res | 2021 |
| 33736735 | Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. | Eur Psychiatry | 2021 |
| 31414981 | Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study. | Psychol Med | 2020 |
| 31613963 | Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium. | Neuro Oncol | 2020 |
| 31813804 | A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome. | Schizophr Res | 2020 |
| 32796005 | Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastoma. | Genome Res | 2020 |
| 31414981 | Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study. | Psychol Med | 2020 |
| 31813804 | A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome. | Schizophr Res | 2020 |
| 32796005 | Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastoma. | Genome Res | 2020 |
| 31613963 | Pediatric high-grade glioma resources from the Children's Brain Tumor Tissue Consortium. | Neuro Oncol | 2020 |
| 31059627 | Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study. | World Psychiatry | 2019 |
| 31693904 | Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. | Cell Rep | 2019 |
| 31607966 | White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder? | Front Psychiatry | 2019 |
| 31508804 | Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study. | Schizophr Bull | 2019 |
| 31474320 | Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma. | Am J Hum Genet | 2019 |
| 31059627 | Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study. | World Psychiatry | 2019 |
| 31693904 | Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. | Cell Rep | 2019 |
| 31474320 | Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma. | Am J Hum Genet | 2019 |
| 31607966 | White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder? | Front Psychiatry | 2019 |
| 31508804 | Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study. | Schizophr Bull | 2019 |
| 29510988 | Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma. | Cancer Discov | 2018 |
| 29880876 | Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma. | Oncogene | 2018 |
| 29510988 | Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma. | Cancer Discov | 2018 |
| 29880876 | Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma. | Oncogene | 2018 |
| 28867147 | LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis. | Cancer Cell | 2017 |
| 28867147 | LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis. | Cancer Cell | 2017 |